Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Taking a Balanced Approach to Monitoring Literature

Posted on September 11th, 2017 by in Pharmacovigilance

In a time when the focus on pharmacovigilance is greater than ever before, literature monitoring presents pharmaceutical companies with significant challenges. Pharmacovigilance groups are looking for ways to efficiently and cost-effectively manage an increasing workload while remaining compliant with regulatory best practices. (more…)

FDA Speeds Up Generic Approval Process

Posted on August 30th, 2017 by in Pharmacovigilance

Healthcare has been in the spotlight for much of the year so far, as Congress has wrestled with the difficult question of how to make it both better and more affordable.

(more…)

Creating a Formula for Precise, Effective Literature Searching

Posted on July 31st, 2017 by in Pharmacovigilance

Even those who are old enough to remember the days before the internet might find it hard to imagine living our lives now without access to digital information tools. People working in pharmacovigilance today may actually shudder at the thought of having to do their jobs without biomedical research solutions. (more…)

The Liabilities of Pharmacovigilance Activities

Posted on June 21st, 2017 by in Pharmacovigilance

There is always a risk that any Pharmacovigilance (PV) activity, even executed with the highest business and ethical standards, and with the highest compliance results, could be challenged, sometimes many years later. As a member of a PV team, you may have to one day justify your actions in front of a group of plaintiff’s lawyers, (more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 14